These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3383544)

  • 1. Pharmacokinetic and pharmacodynamic comparison of mezlocillin and ticarcillin.
    Deeter RG; Barriere SL; Fekety R
    Clin Pharm; 1988 May; 7(5):380-4. PubMed ID: 3383544
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergy between amikacin and ticarcillin or mezlocillin against nosocomial bloodstream isolates.
    Guenthner SH; Chao HP; Wenzel RP
    J Antimicrob Chemother; 1986 Oct; 18(4):550-2. PubMed ID: 3771436
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of mezlocillin, ticarcillin and placebo on blood coagulation and bleeding time in normal volunteers.
    Somani P; Smith MR; Gohara A; Kapila K
    J Antimicrob Chemother; 1983 May; 11 Suppl C():33-41. PubMed ID: 6619040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
    Machka K; Dickert H; Braveny I
    Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticarcillin plus clavulanic acid: pharmacokinetic study in renal failure.
    Stathakis C; Bakounsli I; Iatrou C; Boletis J; Kosmidis J
    Chemioterapia; 1987 Jun; 6(2 Suppl):265-7. PubMed ID: 3509408
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of ticarcillin in patients with cystic fibrosis: a controlled prospective study.
    de Groot R; Hack BD; Weber A; Chaffin D; Ramsey B; Smith AL
    Clin Pharmacol Ther; 1990 Jan; 47(1):73-8. PubMed ID: 2295222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].
    Quentin C; Sageaux JC; Bebear C; Latrille J
    Pathol Biol (Paris); 1983 Jun; 31(6):463-6. PubMed ID: 6224123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of mezlocillin and ticarcillin in the treatment of urinary tract infections.
    Madsen PO; Nielsen OS
    Clin Ther; 1980; 3(4):311-5. PubMed ID: 6456068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary excretion of mezlocillin in patients with hepatic disease.
    Hildebrandt R; Gundert-Remy U; Raedsch R; Sieg A; Stiehl A
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):384-7. PubMed ID: 7582392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of low- and high-dose ticarcillin.
    Guglielmo BJ; Flaherty JF; Batman R; Barriere SL; Gambertoglio JG
    Antimicrob Agents Chemother; 1986 Sep; 30(3):359-60. PubMed ID: 3777901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of mezlocillin disposition with a porcine model.
    DiPiro JT; Davis JB; Boudinot FD; Cheung RP; Sisley JF
    Biopharm Drug Dispos; 1989; 10(6):563-72. PubMed ID: 2611357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evaluation of mezlocillin concentrations in bronchial tissue.
    Pirali F; Ravizzola G; Colombrita D; Flamminio G; Caruso A; Gargiulo F; Peroni L; Manni M; Manca N; Turano A
    J Chemother; 1989 Jul; 1(4 Suppl):509-11. PubMed ID: 16312507
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of in vitro kinetic models in the evaluation of beta-lactamase inhibitors.
    White A; Cooper C; Stokes D
    Chemioterapia; 1987 Jun; 6(2 Suppl):202-4. PubMed ID: 3509934
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacokinetics and antibacterial activity of ticarcillin in 11 patients with cystic fibrosis].
    de Meirleire F; Fauchere JL; Simon G
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):570-2. PubMed ID: 6431381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative review of two new wide-spectrum penicillins: mezlocillin and piperacillin.
    Russo J; Russo ME
    Clin Pharm; 1982; 1(3):207-16. PubMed ID: 6224627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacology of clavulanic acid and ticarcillin combined.
    Scully BE; Steinman R; Chin NX; Neu HC
    Chemioterapia; 1984 Dec; 3(6):385-9. PubMed ID: 6529781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transplacental transfer of 5 antibiotics by in vitro human placental perfusion].
    Akbaraly JP; Guibert S; Leng JJ; Auzerie J
    Pathol Biol (Paris); 1985 May; 33(5):368-72. PubMed ID: 3897968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between mezlocillin and sisomicin in vitro and in patients with normal and various degrees of impaired renal function.
    Kampf D; Schurig R; Bergs A; Förster D
    Clin Nephrol; 1983 Jan; 19(1):37-44. PubMed ID: 6219847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic properties of mezlocillin in ambulatory elderly subjects.
    Meyers BR; Mendelson MH; Srulevitch-Chin E; Bradbury K; McMurdo L; Hirschman SZ
    J Clin Pharmacol; 1987 Sep; 27(9):678-81. PubMed ID: 3680597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of an ion-paired high pressure liquid chromatography for ticarcillin in human serum.
    Zhu Z; Xuan DW; Nightingale CH
    Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):395-8. PubMed ID: 9863157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.